MedPath

L.39 COMP. - TABLET

L.39 COMP. - TABLET

Discontinued
DIN Number

02172208

Drug Class

Human

Market Date

Dec 31, 1995

Company
HC

homeocan inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02172208
AIG Number0627768001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Homeopathic
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification92:02.00*
Health Canada Classification

ACTIVE INGREDIENTS (6)

AMMONIUM NITRATEActive
Strength: 8 D
Monograph: AMMONIUM NITRATE
POTASSIUM IODIDEActive
Strength: 4 D
Monograph: POTASSIUM IODIDE
POTASSIUM PHOSPHATE DIBASICActive
Strength: 3 D
Monograph: POTASSIUM PHOSPHATE DIBASIC
SODIUM CHLORIDEActive
Strength: 8 D
Monograph: SODIUM CHLORIDE
SODIUM NITRATEActive
Strength: 3 D
Monograph: SODIUM NITRATE
SODIUM SULFATEActive
Strength: 6 D
Monograph: SODIUM SULFATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.